Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    Open Studies | "Candidiasis"
Show Display Options
Rank Status Study
21 Recruiting Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
Conditions: Bacterial Vaginosis;   Vulvovaginal Candidiasis;   Trichomoniasis
Intervention: Other: NAAT testing
22 Unknown  Empirical Antifungal Treatment in ICUS
Condition: Invasive Candidiasis
Interventions: Drug: Micafungin;   Drug: PLACEBO
23 Recruiting Optimal Dosage of Caspofungin in Critically Ill Patients
Conditions: Critically Ill;   Suspected Invasive Candidiasis
Intervention: Drug: Caspofungin
24 Recruiting PEACE: Pediatric Antifungal Comparative Effectiveness
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
25 Recruiting Study To Assess The Safety, Pharmacokinetics, And Evaluate The Response To Anidulafungin When Treating Children With Invasive Candidiasis
Condition: Candidemia
Interventions: Drug: anidulafungin;   Drug: fluconazole
26 Unknown  Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
Condition: Pulmonary Candidiasis
Intervention: Drug: fluconazole
27 Recruiting Pharmacokinetics of Micafungin in Patients of Intensive Care Units
Condition: Invasive Candidiasis
Intervention: Other: micafungin
28 Not yet recruiting BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
Condition: Invasive Candidiasis
Intervention:
29 Recruiting Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
Condition: Invasive Candidiasis
Intervention: Drug: Micafungin
30 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
31 Unknown  A Pilot Study for the Use of Biomarkers and Early Treatment of Invasive Candidiasis in Intensive Care Unit (ICU) Patients
Condition: Candidemia
Intervention: Drug: Anidulafungin
32 Unknown  Pre-hospital Risk Factors for Invasive Fungal Infection
Conditions: Acute Myeloid Leukemia;   Aspergillosis;   Candidiasis;   Mycoses
Intervention:
33 Recruiting Immunological Interaction Between the Host and Candida Albicans Biofilm
Condition: Candidiasis
Intervention:
34 Recruiting Observational Program Neo-Penotran® Forte
Conditions: Vaginal Candidiasis;   Bacterial Vaginosis;   Trichomonal Vaginitis
Intervention: Drug: Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
35 Unknown  Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis
Condition: Vaginal Candidiasis
Interventions: Drug: Probiotics (Natural product);   Drug: Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14)
36 Unknown  Biliary Candidiasis - Optimization of Diagnostics and Therapy
Conditions: Secondary Cholangitis;   Bile Duct Strictures of Unknown Origin
Intervention: Procedure: ERCP
37 Unknown  Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
Condition: Candidemia
Intervention: Drug: Interferon-gamma, Recombinant
38 Unknown  Risk Factor and Outcome of Candidemia
Condition: Candidemia
Intervention:
39 Recruiting A Non-interventional Observational Study of Infectious Complications in Cancer Patients
Conditions: Aspergillosis;   Candidemia;   C. Difficile
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years